Source: http://www.google.com/patents/US20020169504?dq=patent:5567455
Timestamp: 2016-09-29 11:48:02
Document Index: 376881174

Matched Legal Cases: ['art 10', 'art 10', 'art 10', 'art 10', 'art 10', 'art 10']

Patent US20020169504 - Mitral valve therapy device, system and method - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsAn assembly and method for effecting the condition of a mitral valve annulus of a heart includes a guide wire configured to be fed into the coronary sinus of the heart, and a mitral valve annulus therapy device configured to be slidingly received on the guide wire and advanced into the coronary sinus...http://www.google.com/patents/US20020169504?utm_source=gb-gplus-sharePatent US20020169504 - Mitral valve therapy device, system and methodAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS20020169504 A1Publication typeApplicationApplication numberUS 09/855,945Publication dateNov 14, 2002Filing dateMay 14, 2001Priority dateMay 14, 2001Also published asCA2447689A1, CA2447689C, DE60227514D1, EP1395202A2, EP1395202A4, EP1395202B1, US6800090, US7270676, US7828843, US20050027351, US20050027353, US20050033419, US20050038507, WO2002100240A2, WO2002100240A3Publication number09855945, 855945, US 2002/0169504 A1, US 2002/169504 A1, US 20020169504 A1, US 20020169504A1, US 2002169504 A1, US 2002169504A1, US-A1-20020169504, US-A1-2002169504, US2002/0169504A1, US2002/169504A1, US20020169504 A1, US20020169504A1, US2002169504 A1, US2002169504A1InventorsClifton Alferness, John Adams, John PowerOriginal AssigneeAlferness Clifton A., Adams John M., Power John MelmothExport CitationBiBTeX, EndNote, RefManPatent Citations (25), Referenced by (153), Classifications (6), Legal Events (5) External Links: USPTO, USPTO Assignment, EspacenetMitral valve therapy device, system and method
BRIEF DESCRIPTION OF THE DRAWINGS [0034] The features of the present invention which are believed to be novel are set forth with particularity in the appended claims. The invention, together with further aspects and advantages thereof, may best be understood by making reference to the following description taken in conjunction with the accompanying drawings, and the several figures of which like reference numerals identify identical elements, and wherein: [0035] [0035]FIG. 1 is a superior view of a human heart with the atria removed; [0036] [0036]FIG. 2 is a perspective view of a mitral valve annulus constricting device embodying the present invention; [0037] [0037]FIG. 3 is a perspective view of an assembly for deploying a mitral valve constricting device in accordance with a preferred embodiment of the present invention; [0038] [0038]FIG. 4 is another perspective view of the assembly of FIG. 3; [0039] [0039]FIG. 5 is a superior view of a human heart similar to that of FIG. 1 and illustrating a method of determining the crossover point of the circumflex artery and the coronary sinus in accordance with a preferred embodiment of the present invention; [0040] [0040]FIG. 6 is another view of a human heart illustrating the method of determining the crossover point of the circumflex artery and the coronary sinus in accordance with the present invention; [0041] [0041]FIG. 7 is another superior view of a human heart illustrating deployment of a mitral valve therapy device in accordance with the preferred embodiment of the present invention; [0042] [0042]FIG. 8 is another superior view of a human heart illustrating an implanted mitral valve therapy device embodying the present invention; [0043] [0043]FIG. 9 is another superior view of a human heart illustrating another mitral valve therapy device embodying the present invention implanted in the heart; [0044] [0044]FIG. 10 is a perspective view of another mitral valve annulus device embodying the present invention.
DETAILED DESCRIPTION OF THE INVENTION [0045] Referring now to FIG. 1, it is a superior view of a human heart 10 with the atria removed to expose the mitral valve 12, the coronary sinus 14, the coronary artery 15, and the circumflex artery 17 of the heart 10 to lend a better understanding of the present invention. Also generally shown in FIG. 1 are the pulmonary valve 22, the aortic valve 24, and the tricuspid valve 26 of the heart 10. [0046] The mitral valve 12 includes an anterior cusp 16, a posterior cusp 18 and an annulus 20. The annulus encircles the cusps 16 and 18 and maintains their spacing to provide a complete closure during a left ventricular contraction. As is well known, the coronary sinus 14 partially encircles the mitral valve 12 adjacent to the mitral valve annulus 20. As is also known, the coronary sinus is part of the venus system of the heart and extends along the AV groove between the left atrium and the left ventricle. This places the coronary sinus essentially within the same plane as the mitral valve annulus making the coronary sinus available for placement of the mitral valve therapy device of the present invention therein. [0047] of particular importance is the physiological relationship of the coronary sinus 14 and the circumflex artery 17. The circumflex artery 17 branches from the coronary artery 15 and supplies blood flow to critical tissue of the heart 10. The circumflex artery passes beneath the coronary sinus 14 at a crossover point 19. It is one aspect of the present invention to avoid constriction of blood flow through the circumflex artery 17 when a mitral valve therapy device is deployed in the coronary sinus 14. [0048] [0048]FIG. 2 shows a mitral valve therapy device 30 embodying the present invention. As may be noted in FIG. 2, the device is elongated and has an arched configuration to at least partially encircle the mitral valve 12 adjacent to the mitral valve annulus 20 when implanted in the coronary sinus 14. The device 30 has an unstressed preformed arched radius smaller than the radius of the dilated mitral valve annulus 20. This causes the device 30 to constrict the mitral valve annulus and impart an inward, generally radial force designated by arrows 32 on the mitral valve annulus 20 when implanted in the coronary sinus of the heart. This force reshapes and returns the mitral valve annulus 20 to its original or substantially original geometry to permit the cusps 16 and 18 to more fully come together for sealing the left atrium during left ventricular contraction. [0049] The device 30 has a cross section dimension to be received by the coronary sinus. It is preferably formed of a resilient material permitting the device to be straightened and/or bent for being advanced into the coronary sinus. After being positioned within the coronary sinus, the device is permitted to assume its preformed arched configuration to act upon the mitral valve annulus as previously described. To that end, the device may be formed of, for example, Nitinol, a nickel titanium alloy, well known in the art. This material, as is well known, is capable of being preformed but manipulated to be straight or partially bent while having sufficient memory to return to its preformed configuration. Stainless steel is also among the materials which may be used in forming the device 30. In order to be received within the coronary sinus, the device may have a cross sectional dimension of, for example, on the order of four or five french. [0050] With continued reference to FIG. 2, the device 30 has a distal end 34 and a proximal end 36. Between the distal end 34 and proximal end 36 the device further includes a channel 38 which is aligned with a bore 40 extending through the distal end 34 and a bore 42 extending through the proximal end 36. The proximal end 36 further includes an integral sleeve 44 which carries a protruding locking pin 46. As will be seen subsequently, the bores 40 and 42 permit the device to be slidingly received by a guide wire during deployment of the device 30. The guide wire, during deployment, is confined within the channel 38. [0051] [0051]FIGS. 3 and 4 illustrate an assembly 50 for deploying or implanting the mitral valve therapy device 30. The assembly 50 includes a guide wire 52, a guide tube 54, and an elongated introducer 56. [0052] The guide wire 52 is preferably an elongated coil. It has an outer dimension to permit the guide wire 52 to be passed through the bores 40 and 42 of the device 30. This enables the device 30 to be slidingly received on the guide wire 52 with the guide wire confined within the channel 38 of the device 30. [0053] The guide tube 54 is elongated and formed of a flexible biocompatible material. It includes an inner lumen 55 permitting the device 30 and the introducer 56 to be received therein. [0054] The introducer 56 preferably takes the form of an elongated coil having an inner channel dimensioned to be received by and slid onto the guide wire 52. At a distal end 58 the introducer includes a sleeve 60 which may be received over the sleeve 44 of the device 30. The introducer sleeve 60 includes a detented slot 62 for releasably receiving the pin 46 of the device 30. This enables the introducer 56 to be releasably locked to the device 30 during deployment of the device. It also permits the introducer to be relocked to the device 30 for extracting the device should it be necessary to remove the device 30 for exchange with another device. [0055] As previously mentioned, the circumflex artery 17 passes under the coronary sinus 14. When the device 30 is deployed, it should not be permitted to exert a force from the coronary sinus against the circumflex artery. Hence, in accordance with one embodiment of the present invention, the device is implanted within the coronary sinus at a position whereby the distal end 34 of the device 30 is proximal to the crossover point of the circumflex artery and the coronary sinus. This requires determination of the crossover point. FIGS. 5 and 6 illustrate how such a determination may be made in accordance with the present invention. [0056] A first elongated member, such as an elongated wire or coil wire 70 is inserted into the circumflex artery 17. The wire 70 may be formed of a material visible under X ray fluoroscopy or be of other material having a coating which is visible under X ray fluoroscopy. Next, a second wire which may be the guide wire 52 is inserted into the coronary sinus 14 by way of the ostium of coronary sinus 13. Again, the wire 52 is preferably of a material visible under X ray fluoroscopy or of another material having a coating which is visible under X ray fluoroscopy. Preferably, the wires 52 and 70 are elongated coils formed of stainless steel. [0057] The heart 10 or at least that portion of the heart 10 where the circumflex artery passes under the coronary sinus is subjected to X ray fluoroscopy. X ray fluoroscopy is well known in the art. The crossover point 19 where the wires 52 and 70 cross and hence where the circumflex artery and coronary sinus cross may then be readily observed by X ray fluoroscopic examination. This locates the crossover point 19 which is to be distal to the distal end 34 of the device 30 when the device 30 is positioned within the coronary sinus. [0058] Once the crossover point 19 has been determined, the device 30 may be deployed. During the deployment of the device, the first wire 70 may be left in the circumflex artery to permit continuous X ray fluoroscopic examination or later X ray fluoroscopic examination to confirm proper device positioning. [0059] [0059]FIG. 7 shows how the assembly 50 may be used to implant the device 30. Presumably the guide wire 52 has already been positioned in the coronary sinus 14 to support the determination of the circumflex artery and coronary sinus crossover point as described above. As also described above, wire 70 may also be left in the heart at this time. [0060] Next, the guide tube 54 is advanced into the heart. The guide tube is advanced over the guide wire 52. The guide wire hence guides the guide tube 54 into the coronary sinus where the device is to be implanted. [0061] When the guide tube 54 is positioned in the coronary sinus, the device 30 and introducer 56 are then advanced into the guide tube 54 and over the guide wire 52. The distal end 58 of the introducer 56 is first releasably locked to the proximal end 36 of the device 30 (FIGS. 3 and 4) by advancing the sleeve 60 of the introducer 56 over the sleeve 44 of the device 30 and inserting the locking pin 46 in the detented locking groove 62. [0062] With the distal end of the introducer 56 thus engaged with the proximal end of the device 30, the device may then be pushed by the introducer 56 into the coronary sinus 14 while being guided by both the guide wire 52 and the guide tube 54. [0063] When the device is positioned within the coronary sinus 14 with its distal end proximal to the crossover point 19 and its position is confirmed by X ray fluoroscopy, the introducer may be removed. This is accomplished by turning the introducer to unlock the pin 46 and retracting the introducer from the guide tube. Then, the guide tube 54 may also be retracted leaving the device in place but still on the guide wire 52. The performance of the device 30 may now be evaluated. If another device of different properties is deemed more appropriate, the device may be readily replaced. Thus is accomplished by reinserting the guide tube over the device, reinserting the introducer, locking the introducer to the device, and removing the device through the guide tube with the introducer. A new device may then be deployed as previously described. [0064] Once a device is deployed that satisfies the requirements of the procedure, the guide wire 52, and the wire 70 if still within the heart, may be removed. This leaves the device 30 in its proper position as illustrated in FIG. 8. Here it may be seen that the device 30 partially encircles the mitral valve 12 within the coronary sinus 14 and adjacent to the mitral valve annulus. The distal end 34 of the device 30 is proximal to the crossover point 19. The proximal end 36 of the device protrudes slightly into the right atrium (not shown) through the ostium of coronary sinus 13. The sleeve 44 and pin 46 remain should subsequent removal of the device be deemed necessary. [0065] [0065]FIG. 9 shows another mitral valve therapy device 130 embodying the present invention. As may be noted in FIG. 9, the device is elongated and has an arched configuration to at least partially encircle the mitral valve 12 adjacent to the mitral valve annulus 20 when implanted in the coronary sinus 14. The device 130 has an unstressed preformed arched radius smaller than the radius of the dilated mitral valve annulus 20 to impart an inward, generally radial force when implanted in the coronary sinus of the heart as shown. This force again returns the mitral valve annulus 20 to its original or substantially original geometry to permit the cusps 16 and 18 to more fully come together for sealing the left atrium during left ventricular contraction. [0066] The device 130 has a cross sectional dimension to be received by the coronary sinus. It is also preferably formed of a resilient material to permit the device to be straightened and/or bent for being advanced into the coronary sinus. After being positioned within the coronary sinus, the device is permitted to assume its preformed arched configuration to act upon the mitral valve annulus as previously described. To that end, the device may be formed of, for example, Nitinol, a nickel titanium alloy. [0067] The device 130 has a distal end 134 and a proximal end 136. Between the distal end 134 and proximal end 136 the device further includes a channel 138 which is aligned with a bore 140 extending through the distal end 134 and a bore 142 extending through the proximal end 136. The proximal end 136 further includes an integral sleeve 144 which carries a protruding locking pin 146. Again, the bores 140 and 142 permit the device to be slidingly received by a guide wire during deployment of the device 130. The guide wire, during deployment, is confined within the channel 138. [0068] The device 130 still further includes a bend 50 at its distal end 134. As will be noted, the distal end 134 extends beyond the crossover point 19 of the circumflex artery 17 and the coronary sinus 14. However, because of the bend 150, the device is precluded from exerting constricting pressure on the circumflex artery 17 even though it extends over the crossover point 19. The device 130 may be implanted using the assembly as previously described. [0069] [0069]FIG. 10 shows still another mitral valve therapy device 230 embodying the present invention. Like the device 30 of FIG. 2, the device 230 is elongated and has an arched configuration to at least partially encircle the mitral valve 12 adjacent to the mitral valve annulus 20 when implanted in the coronary sinus 14. The device 230 has an unstressed preformed arched radius smaller than the radius of the dilated mitral valve annulus 20 to impart an inward, generally radial force on the mitral valve annulus 20 when implanted in the coronary sinus of the heart to return the mitral valve annulus 20 to its original or substantially original geometry permitting the cusps of the mitral valve to more fully come together for sealing the left atrium during left ventricular contraction. [0070] The device 230 has a cross section dimension to be received by the coronary sinus. It is preferably formed of any of the resilient materials previously described. [0071] The device 230 has a distal end 234 and a proximal end 236. Between the distal end 234 and proximal end 236 the device further includes a channel 238 which is aligned with a bore 242 extending through the proximal end 236. The proximal end 236 further includes an integral sleeve 244 which carries a protruding locking pin 246. The bore 242 permits the device to be slidingly received by the guide wire during deployment of the device 230. The guide wire, during deployment, is confined within the channel 238. The assembly 50 of FIGS. 3 and 4 including the guide wire 52, guide tube 54, and elongated introducer 56 may be utilized as described for deploying the device 230. Here, however, only one end of the device need be slidingly received by the guide wire 52 since the device is well confined within the guide tube 54 and the guide wire 52 is confined within the channel 238. [0072] As can thus be seen from the foregoing, the present invention provides a new and improved device, assembly and method for treating mitral regurgitation. The device may be employed with only percutaneous techniques. Further, the mitral valve therapy device may be implanted in a manner which avoids the crossover point of the circumflex artery and coronary sinus. Lastly, the effectiveness of the therapy may be immediately deduced during the implant procedure and permits substitution of devices for optimized results. [0073] While particular embodiments of the present invention have been shown and described, modifications may be made, and it is therefore intended in the appended claims to cover all such changes and modifications which fall within the true spirit and scope of the invention. Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS4164046 *May 16, 1977Aug 14, 1979Cooley DentonValve prosthesisUS4485816 *Jun 25, 1981Dec 4, 1984AlchemiaShape-memory surgical staple apparatus and method for use in surgical suturingUS4550870 *Oct 13, 1983Nov 5, 1985Alchemia Ltd. PartnershipStapling deviceUS5061277 *Sep 2, 1988Oct 29, 1991Baxter International Inc.Flexible cardiac valvular support prosthesisUS5250071 *Sep 22, 1992Oct 5, 1993Target Therapeutics, Inc.Detachable embolic coil assembly using interlocking clasps and method of useUS5261916 *Dec 12, 1991Nov 16, 1993Target TherapeuticsDetachable pusher-vasoocclusive coil assembly with interlocking ball and keyway couplingUS5265601 *May 1, 1992Nov 30, 1993Medtronic, Inc.Dual chamber cardiac pacing from a single electrodeUS5514161 *Apr 4, 1995May 7, 1996Ela Medical S.A.Methods and apparatus for controlling atrial stimulation in a double atrial triple chamber cardiac pacemakerUS5554177 *Mar 27, 1995Sep 10, 1996Medtronic, Inc.Method and apparatus to optimize pacing based on intensity of acoustic signalUS5562698 *Nov 8, 1994Oct 8, 1996Cook IncorporatedIntravascular treatment systemUS5584867 *Apr 4, 1995Dec 17, 1996Ela Medical S.A.Method and apparatus for controlling a double atrial triple chamber cardiac pacemaker having a fallback modeUS5601600 *Sep 8, 1995Feb 11, 1997Conceptus, Inc.Endoluminal coil delivery system having a mechanical release mechanismUS5733325 *May 6, 1996Mar 31, 1998C. R. Bard, Inc.Non-migrating vascular prosthesis and minimally invasive placement systemUS20010049558 *Jan 12, 2001Dec 6, 2001Liddicoat John R.Tissue annuloplasty band and apparatus and method for fashioning, sizing and implanting the sameUS20020035361 *Jul 3, 2001Mar 21, 2002Houser Russell A.Apparatus and methods for treating tissueUS20020042621 *Jun 22, 2001Apr 11, 2002Liddicoat John R.Automated annular plication for mitral valve repairUS20020042651 *Jun 29, 2001Apr 11, 2002Liddicoat John R.Method and apparatus for performing a procedure on a cardiac valveUS20020049468 *Jun 29, 2001Apr 25, 2002Streeter Richard B.Intravascular filter with debris entrapment mechanismUS20020055774 *Sep 7, 2001May 9, 2002Liddicoat John R.Fixation band for affixing a prosthetic heart valve to tissueUS20020065554 *Oct 25, 2001May 30, 2002Streeter Richard B.Mitral shieldUS20020095167 *Oct 23, 2001Jul 18, 2002Liddicoat John R.Automated annular plication for mitral valve repairUS20020103533 *Jan 30, 2001Aug 1, 2002Langberg Jonathan J.Percutaneous mitral annuloplasty and cardiac reinforcementUS20020138044 *Oct 26, 2001Sep 26, 2002Streeter Richard B.Intracardiovascular access (ICVATM) systemUS20030018358 *Jul 3, 2002Jan 23, 2003Vahid SaadatApparatus and methods for treating tissueUS20030069636 *Nov 26, 2002Apr 10, 2003Solem Jan OttoMethod for treatment of mitral insufficiency* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS6656221Feb 5, 2002Dec 2, 2003Viacor, Inc.Method and apparatus for improving mitral valve functionUS6676702 *May 14, 2001Jan 13, 2004Cardiac Dimensions, Inc.Mitral valve therapy assembly and methodUS6764510Jan 9, 2002Jul 20, 2004Myocor, Inc.Devices and methods for heart valve treatmentUS6793673 *Dec 26, 2002Sep 21, 2004Cardiac Dimensions, Inc.System and method to effect mitral valve annulus of a heartUS6797001 *Mar 11, 2002Sep 28, 2004Cardiac Dimensions, Inc.Device, assembly and method for mitral valve repairUS6824562May 8, 2002Nov 30, 2004Cardiac Dimensions, Inc.Body lumen device anchor, device and assemblyUS6890353Mar 22, 2002May 10, 2005Viacor, Inc.Method and apparatus for reducing mitral regurgitationUS6908478 *Dec 5, 2001Jun 21, 2005Cardiac Dimensions, Inc.Anchor and pull mitral valve device and methodUS6908482 *May 3, 2002Jun 21, 2005Edwards Lifesciences CorporationThree-dimensional annuloplasty ring and templateUS6949122Nov 1, 2001Sep 27, 2005Cardiac Dimensions, Inc.Focused compression mitral valve device and methodUS6960229May 2, 2003Nov 1, 2005Cardiac Dimensions, Inc.Device and method for modifying the shape of a body organUS6966926 *Sep 10, 2003Nov 22, 2005Cardiac Dimensions, Inc.Mitral valve therapy assembly and methodUS6976995Jan 30, 2002Dec 20, 2005Cardiac Dimensions, Inc.Fixed length anchor and pull mitral valve device and methodUS6989028 *Jan 30, 2002Jan 24, 2006Edwards Lifesciences AgMedical system and method for remodeling an extravascular tissue structureUS6997951Dec 24, 2002Feb 14, 2006Edwards Lifesciences AgMethod and device for treatment of mitral insufficiencyUS7004958Mar 6, 2002Feb 28, 2006Cardiac Dimensions, Inc.Transvenous staples, assembly and method for mitral valve repairUS7011682 *Aug 5, 2003Mar 14, 2006Edwards Lifesciences AgMethods and apparatus for remodeling an extravascular tissue structureUS7037334Jul 18, 2003May 2, 2006Mitralign, Inc.Method and apparatus for catheter-based annuloplasty using local plicationsUS7052487Oct 25, 2002May 30, 2006Cohn William EMethod and apparatus for reducing mitral regurgitationUS7125420May 27, 2003Oct 24, 2006Viacor, Inc.Method and apparatus for improving mitral valve functionUS7144363Oct 11, 2002Dec 5, 2006Extensia Medical, Inc.Systems for heart treatmentUS7166127Sep 24, 2004Jan 23, 2007Mitralign, Inc.Tissue fastening systems and methods utilizing magnetic guidanceUS7179282May 2, 2003Feb 20, 2007Cardiac Dimensions, Inc.Device and method for modifying the shape of a body organUS7186264Mar 29, 2002Mar 6, 2007Viacor, Inc.Method and apparatus for improving mitral valve functionUS7241310Jan 14, 2003Jul 10, 2007Taylor Daniel CMethod and apparatus for reducing mitral regurgitationUS7270676Aug 24, 2004Sep 18, 2007Cardiac Dimensions, Inc.Mitral valve therapy device, system and methodUS7294148Apr 29, 2004Nov 13, 2007Edwards Lifesciences CorporationAnnuloplasty ring for mitral valve prolapseUS7314485Feb 3, 2003Jan 1, 2008Cardiac Dimensions, Inc.Mitral valve device using conditioned shape memory alloyUS7316708Dec 5, 2002Jan 8, 2008Cardiac Dimensions, Inc.Medical device delivery systemUS7367991Jun 14, 2004May 6, 2008Edwards Lifesciences CorporationConformal tricuspid annuloplasty ring and templateUS7485143 *Nov 15, 2002Feb 3, 2009Abbott Cardiovascular Systems Inc.Apparatuses and methods for heart valve repairUS7507252 *Aug 5, 2003Mar 24, 2009Edwards Lifesciences AgAdjustable transluminal annuloplasty systemUS7575595Mar 22, 2006Aug 18, 2009Edwards Lifesciences CorporationAnnuloplasty ring and holder combinationUS7591826 *Dec 28, 2000Sep 22, 2009Cardiac Dimensions, Inc.Device implantable in the coronary sinus to provide mitral valve therapyUS7666224Jul 7, 2005Feb 23, 2010Edwards Lifesciences LlcDevices and methods for heart valve treatmentUS7678145Jul 1, 2005Mar 16, 2010Edwards Lifesciences LlcDevices and methods for heart valve treatmentUS7695425Feb 17, 2004Apr 13, 2010Edwards Lifesciences LlcHeart wall tension reduction apparatus and methodUS7722523Jul 9, 2002May 25, 2010Edwards Lifesciences LlcTransventricular implant tools and devicesUS7740638Jun 22, 2010Abbott Cardiovascular Systems Inc.Apparatuses and methods for heart valve repairUS7749249Jul 6, 2010Kardium Inc.Method and device for closing holes in tissueUS7766812Apr 14, 2006Aug 3, 2010Edwards Lifesciences LlcMethods and devices for improving mitral valve functionUS7828819Nov 9, 2010Advanced Cardiovascular Systems, Inc.Cord locking mechanism for use in small systemsUS7828843Aug 24, 2004Nov 9, 2010Cardiac Dimensions, Inc.Mitral valve therapy device, system and methodUS7837610Aug 2, 2006Nov 23, 2010Kardium Inc.System for improving diastolic dysfunctionUS7842085Sep 1, 2006Nov 30, 2010Vaso AdzichAnnuloplasty ring and holder combinationUS7879087Feb 1, 2011Edwards Lifesciences CorporationMitral and tricuspid annuloplasty ringsUS7883539Apr 23, 2002Feb 8, 2011Edwards Lifesciences LlcHeart wall tension reduction apparatus and methodUS7914577Mar 29, 2011Advanced Cardiovascular Systems, Inc.Apparatuses and methods for heart valve repairUS7927370Apr 19, 2011Advanced Cardiovascular Systems, Inc.Valve aptation assist deviceUS7935145Jun 30, 2004May 3, 2011Edwards Lifesciences CorporationAnnuloplasty ring for ischemic mitral valve insuffuciencyUS7942927Mar 9, 2005May 17, 2011Baker Medical Research InstituteTreating valve failureUS7942928May 17, 2011Advanced Cardiovascular Systems, Inc.Valve aptation assist deviceUS7951196Feb 2, 2006May 31, 2011Edwards Lifesciences CorporationAnnuloplasty ring for mitral valve prolapseUS7959673Jun 14, 2011Edwards Lifesciences CorporationDegenerative valvular disease specific annuloplasty ringsUS7981152Jul 19, 2011Advanced Cardiovascular Systems, Inc.Vascular delivery system for accessing and delivering devices into coronary sinus and other vascular sitesUS7998112Aug 16, 2011Abbott Cardiovascular Systems Inc.Deflectable catheter assembly and method of making sameUS8016784Dec 18, 2003Sep 13, 2011Abbott Cardiovascular Systems Inc.Deflectable catheter assembly having compression compensation mechanismUS8070804Dec 6, 2011Abbott Cardiovascular Systems Inc.Apparatus and methods for heart valve repairUS8070805Jan 25, 2010Dec 6, 2011Edwards Lifesciences LlcDevices and methods for heart valve treatmentUS8114155Apr 14, 2008Feb 14, 2012Edwards Lifesciences CorporationAnnuloplasty ring with offset free endsUS8123800Apr 14, 2005Feb 28, 2012Edwards Lifesciences CorporationThree-dimensional annuloplasty ring and templateUS8133272May 11, 2010Mar 13, 2012Advanced Cardiovascular Systems, Inc.Apparatuses and methods for heart valve repairUS8142493Mar 27, 2012Mitralign, Inc.Method of heart valve repairUS8142495May 15, 2007Mar 27, 2012Edwards Lifesciences AgSystem and a method for altering the geometry of the heartUS8150499Nov 19, 2010Apr 3, 2012Kardium Inc.Automatic atherectomy systemUS8187324Jun 1, 2006May 29, 2012Advanced Cardiovascular Systems, Inc.Telescoping apparatus for delivering and adjusting a medical device in a vesselUS8226711Jul 24, 2012Edwards Lifesciences, LlcValve to myocardium tension members device and methodUS8236050Dec 18, 2007Aug 7, 2012Edwards Lifesciences CorporationMitral annuloplasty ring having upward bowsUS8267852Jul 8, 2010Sep 18, 2012Edwards Lifesciences, LlcHeart wall tension reduction apparatus and methodUS8337524Dec 25, 2012Kardium Inc.Method and device for closing holes in tissueUS8449605May 28, 2013Kardium Inc.Method for anchoring a mitral valveUS8460173Jun 11, 2013Edwards Lifesciences, LlcHeart wall tension reduction apparatus and methodUS8460371Oct 21, 2003Jun 11, 2013Mitralign, Inc.Method and apparatus for performing catheter-based annuloplasty using local plicationsUS8489172Jan 25, 2008Jul 16, 2013Kardium Inc.Liposuction systemUS8506624Dec 2, 2011Aug 13, 2013Edwards Lifesciences, LlcDevices and methods for heart valve treatmentUS8529621Mar 9, 2012Sep 10, 2013Edwards Lifesciences CorporationMethods of repairing an abnormal mitral valveUS8532746Feb 24, 2012Sep 10, 2013Kardium Inc.Automatic atherectomy systemUS8568473Dec 15, 2006Oct 29, 2013Georgia Tech Research CorporationSystems and methods for enabling heart valve replacementUS8579967Apr 11, 2011Nov 12, 2013Advanced Cardiovascular Systems, Inc.Valve aptation assist deviceUS8591576Feb 14, 2012Nov 26, 2013Edwards Lifesciences AgMethod for altering the geometry of the heartUS8672998Apr 29, 2013Mar 18, 2014Kardium Inc.Method for anchoring a mitral valveUS8685083Jun 26, 2006Apr 1, 2014Edwards Lifesciences CorporationApparatus, system, and method for treatment of posterior leaflet prolapseUS8709074Feb 6, 2012Apr 29, 2014Edwards Lifesciences AgMethod and device for treatment of mitral insufficiencyUS8764821Mar 16, 2012Jul 1, 2014Edwards Lifesciences CorporationDegenerative vavlular disease specific annuloplasty ring setsUS8845723Mar 13, 2007Sep 30, 2014Mitralign, Inc.Systems and methods for introducing elements into tissueUS8864822Mar 13, 2007Oct 21, 2014Mitralign, Inc.Devices and methods for introducing elements into tissueUS8906011Nov 16, 2007Dec 9, 2014Kardium Inc.Medical device for use in bodily lumens, for example an atriumUS8911461Nov 5, 2007Dec 16, 2014Mitralign, Inc.Suture cutter and method of cutting sutureUS8915960Aug 30, 2011Dec 23, 2014Edwards Lifesciences CorporationPhysiologic tricuspid annuloplasty ringUS8920411Jun 28, 2006Dec 30, 2014Kardium Inc.Apparatus and method for intra-cardiac mapping and ablationUS8932287Mar 23, 2011Jan 13, 2015Kardium Inc.Medical device for use in bodily lumens, for example an atriumUS8932350Nov 28, 2011Jan 13, 2015Edwards Lifesciences CorporationReduced dehiscence annuloplasty ringUS8940002Sep 28, 2011Jan 27, 2015Kardium Inc.Tissue anchor systemUS8951286Nov 19, 2008Feb 10, 2015Mitralign, Inc.Tissue anchor and anchoring systemUS8979923Sep 24, 2004Mar 17, 2015Mitralign, Inc.Tissue fastening systems and methods utilizing magnetic guidanceUS9011423Mar 11, 2013Apr 21, 2015Kardium, Inc.Systems and methods for selecting, activating, or selecting and activating transducersUS9011529Apr 27, 2011Apr 21, 2015Edwards Lifesciences CorporationMitral annuloplasty rings with sewing cuffUS9017320Mar 11, 2013Apr 28, 2015Kardium, Inc.Systems and methods for activating transducersUS9017321Mar 11, 2013Apr 28, 2015Kardium, Inc.Systems and methods for activating transducersUS9050066May 20, 2011Jun 9, 2015Kardium Inc.Closing openings in anatomical tissueUS9072511Mar 15, 2012Jul 7, 2015Kardium Inc.Medical kit for constricting tissue or a bodily orifice, for example, a mitral valveUS9101472Feb 7, 2013Aug 11, 2015Edwards Lifesciences CorporationActive holder for annuloplasty ring deliveryUS9119633Mar 5, 2013Sep 1, 2015Kardium Inc.Apparatus and method for intra-cardiac mapping and ablationUS9119634Nov 18, 2014Sep 1, 2015Kardium Inc.Apparatus and method for intra-cardiac mapping and ablationUS9125742Dec 15, 2006Sep 8, 2015Georgia Tech Research FoundationPapillary muscle position control devices, systems, and methodsUS9149359Feb 9, 2012Oct 6, 2015Edwards Lifesciences CorporationThree-dimensional annuloplasty ringUS9149602Apr 22, 2005Oct 6, 2015Advanced Cardiovascular Systems, Inc.Dual needle delivery systemUS9192468Jan 23, 2014Nov 24, 2015Kardium Inc.Method for anchoring a mitral valveUS9198592Nov 18, 2014Dec 1, 2015Kardium Inc.Systems and methods for activating transducersUS9198757Jul 7, 2009Dec 1, 2015Edwards Lifesciences, LlcMethods and devices for improving mitral valve functionUS9204964Jun 13, 2013Dec 8, 2015Kardium Inc.Medical device, kit and method for constricting tissue or a bodily orifice, for example, a mitral valveUS9259218Feb 26, 2013Feb 16, 2016Mitralign, Inc.Tissue anchor and anchoring systemUS9259264Apr 14, 2015Feb 16, 2016Kardium Inc.Systems and methods for activating transducersUS9326858Feb 5, 2013May 3, 2016Edwards Lifesciences CorporationFlexible annuloplasty ringUS9358111Aug 27, 2013Jun 7, 2016Mitralign, Inc.Tissue anchors, systems and methods, and devicesUS9358112Dec 19, 2013Jun 7, 2016Mitralign, Inc.Method and apparatus for catheter-based annuloplasty using local plicationsUS9414922Feb 9, 2012Aug 16, 2016Edwards Lifesciences CorporationThree-dimensional annuloplasty ringUS9439713Apr 14, 2015Sep 13, 2016Kardium Inc.Systems and methods for activating transducersUS20020087173 *Dec 28, 2000Jul 4, 2002Alferness Clifton A.Mitral valve constricting device, system and methodUS20020151961 *Jan 30, 2002Oct 17, 2002Lashinski Randall T.Medical system and method for remodeling an extravascular tissue structureUS20030078465 *Oct 11, 2002Apr 24, 2003Suresh PaiSystems for heart treatmentUS20030083538 *Nov 1, 2001May 1, 2003Cardiac Dimensions, Inc.Focused compression mitral valve device and methodUS20030208264 *May 3, 2002Nov 6, 2003Mccarthy Patrick M.Three-dimensional annuloplasty ring and templateUS20030212453 *May 8, 2002Nov 13, 2003Cardiac Dimensions, Inc.Body lumen device anchor, device and assemblyUS20040039443 *Dec 24, 2002Feb 26, 2004Solem Jan OttoMethod and device for treatment of mitral insufficiencyUS20040127980 *Dec 26, 2002Jul 1, 2004Cardiac Dimensions, Inc.System and method to effect the mitral valve annulus of a heartUS20040133062 *Oct 8, 2003Jul 8, 2004Suresh PaiMinimally invasive cardiac force transfer structuresUS20040153052 *Sep 10, 2003Aug 5, 2004Cardiac Dimensions, Inc.Mitral valve therapy assembly and methodUS20040220654 *May 2, 2003Nov 4, 2004Cardiac Dimensions, Inc.Device and method for modifying the shape of a body organUS20050043791 *Jun 14, 2004Feb 24, 2005Mccarthy Patrick M.Three-dimensional annuloplasty ring and templateUS20050131533 *Jun 30, 2004Jun 16, 2005Ottavio AlfieriAnnuloplasty rings for repair of abnormal mitral valvesUS20050182487 *Apr 14, 2005Aug 18, 2005Mccarthy Patrick M.Three-dimensional annuloplasty ring and templateUS20050197692 *May 2, 2005Sep 8, 2005Extensia Medical, Inc.Systems for heart treatmentUS20050197693 *May 2, 2005Sep 8, 2005Extensia Medical, Inc.Systems for heart treatmentUS20050197694 *May 2, 2005Sep 8, 2005Extensia Medical, Inc.Systems for heart treatmentUS20050261704 *May 9, 2005Nov 24, 2005Mathis Mark LMitral valve therapy assembly and methodUS20060082069 *Oct 7, 2005Apr 20, 2006Malavazi Vedacoes Industriais LtdaBearing-supported mechanical seal for progressive cavity pumpsUS20070156234 *Sep 1, 2006Jul 5, 2007Vaso AdzichApparatus, system, and method for delivering an annuloplasty ringUS20070213812 *Jun 1, 2006Sep 13, 2007Webler William EApparatuses and methods for delivering/deploying a medical device in a vesselUS20080058924 *Sep 1, 2006Mar 6, 2008Aaron IngleSaddle-shaped annuloplasty ringUS20080086203 *Oct 5, 2007Apr 10, 2008Roberts Harold GMitral and tricuspid annuloplasty ringsUS20080097593 *Dec 18, 2007Apr 24, 2008Bolling Steven FMitral Annuloplasty Ring Having Upward BowsUS20080208331 *Apr 14, 2008Aug 28, 2008Edwards Lifesciences CorporationAnnuloplasty ring with offset free endsUS20080288060 *Jul 6, 2005Nov 20, 2008Baker Medical Research InstituteTreating Valvular InsufficiencyUS20090157176 *Feb 8, 2008Jun 18, 2009Alain CarpentierAnnuloplasty rings for correcting degenerative valvular diseasesUS20090287303 *Nov 19, 2009Edwards Lifesciences CorporationPhysiologically harmonized tricuspid annuloplasty ringUS20100023117 *Dec 15, 2006Jan 28, 2010Georgia Tech Research CorporationPapillary muscle position control devices, systems, & methodsUS20110224786 *Sep 15, 2011Edwards Lifesciences CorporationDegenerative Valvular Disease Specific Annuloplasty RingsUS20110238171 *Sep 29, 2011Carpentier Alain FMitral annuloplasty rings with sewing cuffEP3037065A1Dec 17, 2004Jun 29, 2016Cardiac Dimensions Pty. Ltd.Device for modifying the shape of a body organWO2003049648A2 *Dec 3, 2002Jun 19, 2003Cardiac Dimensions, Inc.Anchor and pull mitral valve device and methodWO2003049648A3 *Dec 3, 2002Sep 18, 2003Cardiac Dimensions IncAnchor and pull mitral valve device and methodWO2005062837A2Dec 17, 2004Jul 14, 2005Cardiac Dimensions, Inc.Device for modifying the shape of a body organ* Cited by examinerClassifications U.S. Classification623/2.36, 606/151International ClassificationA61F2/24Cooperative ClassificationY10S623/904, A61F2/2451European ClassificationA61F2/24R4Legal EventsDateCodeEventDescriptionAug 20, 2001ASAssignmentOwner name: CARDIAC DIMENSIONS, INC., WASHINGTONFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ALFERNESS, CLIFTON A.;ADAMS, JOHN M.;POWER, JOHN MELMOTH;REEL/FRAME:012091/0491;SIGNING DATES FROM 20010524 TO 20010528Mar 7, 2008FPAYFee paymentYear of fee payment: 4Mar 7, 2012FPAYFee paymentYear of fee payment: 8Apr 24, 2014ASAssignmentOwner name: CARDIAC DIMENSIONS PTY. LTD., WASHINGTONFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CARDIAC DIMENSIONS, INC.;REEL/FRAME:032759/0069Effective date: 20140411Mar 23, 2016FPAYFee paymentYear of fee payment: 12RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services